The only single-use
published clinical data
EXALTTM Model D Single-Use Duodenoscope / Clinical Data
Clinical data for EXALT™ Model D Single-Use Duodenoscope
EXALT Model D is the world’s only single-use duodenoscope with peer-reviewed, published data, including one trial where patients were consecutively enrolled. Explore the data and get physician perspectives about high-risk patient selection.
Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography
In a consecutive case series testing the feasibility, preliminary safety, and performance of a single-use duodenoscope, 60 ERCPs of all four ASGE complexity levels were completed across six sites in the United States for indications including pancreaticobiliary stone clearance, stent placement, exchange and/or removal and balloon dilation.1
100% of ERCP procedures were successfully performed
96.7% of ERCP procedures were completed with EXALT Model D alone and 3.3% with crossover to a reusable duodenoscope
The median overall physician satisfaction for the EXALT Model D Single-Use duodenoscope scope by physicians was 9 out of 10
EXALT Model D clinical trial evaluation
Dr. Kenneth Binmoeller discusses the clinical evaluation of the EXALT Model D Single-Use Duodenoscope and how it helps support the readiness of the device for clinical use.
“We decided to do a trial, even though it wasn’t mandated by the FDA which is fairly unprecedented. We wanted to reassure physicians that EXALT Model D was not going to compromise the quality of the procedure. We had expert clinicians, who know the nuances of the procedure, confirm that EXALT Model D performed as expected. The feedback we received from clinicians as part of this trial was invaluable.”
Dr. Brian Dunkin, Chief Medical Officer,
Boston Scientific Endoscopy
Bang JY, et al. | Gut 2020
Equivalent performance of single-use and reusable duodenoscopes in a randomised trial2
This randomised trial of 98 patients compared the performance of the EXALT Model D Single-Use Duodenoscope with reusable duodenoscopes in patients undergoing ERCP.
- Overall technical performance and safety profile were similar between the EXALT Model D Single-Use Duodenoscope and reusable duodenoscopes.
- 46 out of 48 patients were successfully cannulated using the EXALT Model D Single-Use Duodenoscope.
- Median number of attempts to achieve successful cannulation was significantly lower for the EXALT Model D Single-Use Duodenoscope as compared to reusable duodenoscopes.
Napolean N, et al. | Digestive Endoscopy 2021
Evaluation of the performance of a single-use duodenoscope: Prospective multi-center study3
In a consecutive case series evaluating the feasibility, safety and performance of a single-use duodenoscope, 60 ERCPs of all four ASGE complexity levels were completed across six sites in France for indications including pancreaticobiliary stone clearance, stent placement and/or removal and balloon dilation.
- 95% of ERCP procedures were completed with EXALT Model D alone. Three procedures required cross-over to a reusable duodenoscope and were also unsuccessful.
- The median overall physician satisfaction for the EXALT Model D Single-Use duodenoscope scope by physicians was 9 out of 10.
- Demonstrates EXALT Model D’s pre-market clinical trial results can be independently reproduced.
The ERCP patient: Risk factors for infection
Although the risk for post-ERCP infection is rare, some patients are more vulnerable to infection than others. Read this in-depth whitepaper to better understand the factors that may impact a patient’s risk for infection during ERCP.Read the whitepaper
Physicians discuss high risk patient selection
Watch the videos below to hear two physician perspectives on patient selection for EXALT Model D and why it may make a clinically appropriate choice for immunocompromised patients.
Dr. Kenneth Binmmoeller
How do we start with patient selection?
Dr. Kenneth Binmoeller discusses how to start and the path forward for using disposable scopes.
Professor Alessandro Repici
Do we require a patient selection protocol?
Professor Alessandro Repici talks about which patients you may want to consider for a single-use scope if not adopting for all patients.